|
Mechanismadrenergic receptor agonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Sinapis Group
0 Patents (Medical) associated with Sinapis Group
100 Deals associated with Sinapis Group
100 Translational Medicine associated with Sinapis Group